Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil

The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used. In this case report are described two cases of severe pemphigus vulgaris re...

Descripción completa

Detalles Bibliográficos
Autores principales: Biot, Stephanie Del Rio Navarrete, Franco, Joanna Pimenta de Araujo, Lima, Ricardo Barbosa, Pereira, Henrique Novo Costa, Marques, Luiz Paulo José, Martins, Carlos José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230671/
https://www.ncbi.nlm.nih.gov/pubmed/25387507
http://dx.doi.org/10.1590/abd1806-4841.20143128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230671/
https://www.ncbi.nlm.nih.gov/pubmed/25387507
http://dx.doi.org/10.1590/abd1806-4841.20143128

Ejemplares similares